Overview
- Former Titans running back Chris Johnson disclosed on Good Morning America that he was diagnosed with amyotrophic lateral sclerosis in 2025 and that the disease has advanced quickly.
- Johnson now communicates with an eye‑triggered speech‑generating device that uses recordings of his own voice because ALS has already taken his ability to speak.
- He and his medical team say his case is sporadic ALS and that his care includes standard‑of‑care medications plus participation in an experimental inflammation‑targeting clinical trial led by Dr. Merit Cudkowicz.
- The public interview on June 29 prompted statements of support from the Tennessee Titans and peers across the sports world and has led some former players to reassess their treatment options.
- ALS is a progressive, fatal neurological disease with no cure and typical survival measured in years, so Johnson’s disclosure may drive earlier diagnosis, more public attention and increased support for trials and research.